IMMUNE RESPONSE TO HEPATITIS VIRUS TYPE B IN DOWN'S SYNDROME AND OTHER MENTALLY RETARDED PATIENTS

Abstract
Hollinger, F. B., R. K. Goyal, T. Hersh, H. C. Powell, R. J. Schulman and J. L. Melnick (Baylor College of Medicine, Houston, Texas 77025). Immune response to hepatitis virus type B in Down's syndrome and other mentally retarded patients. Am J Epidemiol 95: 356–362, 1972.—A high prevalence of Australia (Au) antigen (20%) and antibody (26%) was detected in the sera of 160 Down's syndrome (DS) residents at a state mental institution in Texas. To determine if the DS patients were more susceptible to infections with hepatitis B virus, 33 patients with other mental disorders were individually matched with 33 DS patients. Au or anti-Au occurred with similar frequency in each group indicating equal exposure to the agent. Examined separately, Au antigen was observed in 36% of the DS patients compared to only 12% of the other patients. Conversely, anti-Au was detected in only 18% of the DS patients in contrast to 45% of the other patients. Thus, among equally exposed residents an immunologic difference in the host response was observed.